Gallagher Patrick Stephen 4
4 · Sensei Biotherapeutics, Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Gallagher Patrick Stephen
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-01+150,000→ 150,000 totalExercise: $1.91Exp: 2032-05-31→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest and become exercisable as to 25% of the shares underlying the option on June 1, 2023, and the remaining 75% of the shares underlying the Option shall vest and become exercisable in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.